Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BIO-TECHNE Corp TECH

Technology Scientific & Technical Instruments
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are... see more

Recent & Breaking News (NDAQ:TECH)

Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues

PR Newswire July 11, 2019

Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland

PR Newswire July 9, 2019

Bio-Techne China Recognized With "Decade of Contribution Award"

PR Newswire June 26, 2019

Bio-Techne Appoints Rupert Vessey to Board of Directors

PR Newswire June 25, 2019

FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx(TM) Prostate IntelliScore(TM) (EPI) Test

PR Newswire June 17, 2019

Bio-Techne Receives Approval To Offer The ExoDx(TM) Prostate Intelliscore(TM) (EPI) Test In New York State

PR Newswire June 13, 2019

Bio-Techne To Acquire B-MoGen Biotechnologies Inc.

PR Newswire June 4, 2019

Bio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

PR Newswire June 3, 2019

Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics

PR Newswire May 28, 2019

Bio-Techne To Present At The UBS Global Healthcare Conference

PR Newswire May 14, 2019

Roche expands partnership with Bio-Techne to offer drug discovery researchers new chromogenic detection options for mRNA ISH tissue analysis

PR Newswire May 6, 2019

Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

PR Newswire May 2, 2019

Bio-Techne Declares Dividend

PR Newswire April 30, 2019

Bio-Techne Releases Third Quarter Fiscal 2019 Results

PR Newswire April 30, 2019

Elpiscience and Bio-Techne Announce Strategic Collaboration

PR Newswire April 22, 2019

Bio-Techne To Host Conference Call On April 30, 2019 To Announce Third Quarter 2019 Financial Results

PR Newswire April 9, 2019

Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling

GlobeNewswire March 28, 2019

Bio-Techne Scores A Trio Of CiteAb 2019 Awards

PR Newswire March 5, 2019

Bio-Techne To Present At The Barclays Global Healthcare Conference

PR Newswire March 5, 2019

Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics

PR Newswire February 26, 2019